FitLife Brands Announces Q3 2026 Results; Details Pending
Read source articleWhat happened
FitLife Brands issued a press release on November 16, 2026, announcing third quarter 2026 financial results, but the release did not include any financial figures. The company's most recent detailed report, the DeepValue master report dated August 2026, covers Q2 2026 and highlights ongoing challenges: legacy brand revenue declined 23% year-over-year in Q2, consolidated gross margin fell to 37.0% from 42.8% a year earlier, and net leverage stood at 4.2x. The Q3 period ended September 30, 2026, and the company faced a tighter senior funded debt-to-EBITDA covenant of 2.50x beginning that quarter, making debt reduction and EBITDA generation critical. While Irwin Naturals contributed $14.1 million in Q2 revenue and showed sequential growth, the sustainability of that growth and stabilization of legacy brands remain uncertain. Investors must await the 10-Q filing to assess whether the company made progress on these fronts.
Implication
The Q3 report is a critical test of the investment thesis: if legacy revenue declines persist above 20% and gross margin fails to hold near 37%, the bear case strengthens; conversely, improving trends would support the bull case. The company must demonstrate compliance with the 2.50x leverage covenant and show that Irwin's growth is offsetting legacy erosion. At a current price around $10.80 (as of August 2026), the stock trades at 16.4x earnings, leaving limited margin for error. We maintain a wait-and-see stance until the 10-Q is filed.
Thesis delta
No change to the prior WAIT rating; the announcement of Q3 results without financial details does not alter the thesis. The key metrics to monitor remain legacy revenue, Irwin growth, gross margin, and covenant compliance.
Confidence
Low